CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans- retinoic acid and chemotherapy

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1295-1300

  Ferrara, Felicetto ^a   Morabito, Fortunato ^a   Martino, Bruno ^a   Specchia, Giorgina ^a   Liso, Vincenzo ^a   Nobile, Francesco ^a   Boccuni, Piernicola ^a   Di Noto, Rosa ^a   Pane, Fabrizio ^a   Annunziata, Mario ^a   Schiavone, Ettore Mariano ^a   De Simone, Mariacarla ^a   Guglielmi, Cesare ^a   Del Vecchio, Luigi ^a   Lo Coco, Francesco ^a  

^a CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; IDARUBICIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; HUMAN; LEUKEMIA REMISSION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0034061846     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1295     Document Type: Article

References (39)

1. Grignani F, Fagioli M, Alcalay M, et al: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10-25, 1994
2. Lo Coco F, Diverio D, Falini B, et al: Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 94:12-22, 1999
3. Slack JL, Gallagher RE: The molecular biology of acute promyelocytic leukemia. Cancer Treat Res 99:75-124, 1999
4. Warrell RP Jr: Pathogenesis and management of acute promyelocytic leukemia. Annu Rev Med 47:555-565, 1996
5. Fenaux P, Chomienne C, Degos L: Acute promyelocytic leukemia: Biology and treatment. Semin Oncol 24:92-102, 1997
6. Lo Coco F, Nervi C, Avvisati, et al: Acute promyelocytic leukemia: A curable disease. Leukemia 12:1866-1880, 1998
7. Chou WC, Tang JL, Yao M, et al: Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment. Leukemia 11:921-928, 1997
8. Mandelli F, Diverio D, Avvisati G, et al: Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy: Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 90:1014-1021, 1997
9. Fenaux P, Chastang C, Sanz MA, et al: A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 94:1192-1200, 1999
10. Tallman MS, Andersen JW, Schiffer CA, et al: All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021-1028, 1997
11. Asou N, Adachi K, Tamura J, et al: Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: Japan Adult Leukemia Study Group. J Clin Oncol 16:78-85, 1998
12. Lengfelder E, Reichert A, Schoch C, et al: Molecular remission of PML/RAR alpha after TAD/HAM double induction therapy combined with all-trans retinoic acid, TAD consolidation and monthly maintenance in patients with acute promyelocytic leukemia. Blood 92:403a, 1998 (abstr)
13. Sanz MA, Martin G, Rayon C, et al: A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR alpha-positive acute promyelocytic leukemia. Blood 94:3015-21, 1999
14. Burnett AK, Grimwade D, Solomon E, et al: Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Results of the Randomized MRC trial. Blood 93:4131-4143, 1999
15. Mandelli F, Petti MC, Lo Coco F: Therapy of acute myeloid leukemia: Towards a patient-oriented approach. Haematologica 83: 1015-1023, 1998
16. Paietta E, Andersen J, Gallagher R, et al: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108-1112, 1994
17. Guglielmi C, Martelli MP, Diverio D, et al: Immunophenotype of adult and childhood acute promyelocytic leukemia: Correlation with morphology, type of PML gene breakpoint, and clinical outcome - A cooperative Italian study on 196 cases. Br J Haematol 102:1035-1041, 1998
18. Thomas X, Anglaret B, Campos L, et al: Expression of beta 1-integrins and pseudo-immunoglobulins on acute promyelocytic leukemia cells and its modifications during in vitro differentiation. Leuk Res 22:61-68, 1998
19. Marchetti M, Falanga A, Giovanelli S, et al: All-trans retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4. Br J Haematol 93:360-366, 1996
20. Hsu HC, Tsai WH, Chen PG, et al: In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur J Haematol 63:11-18, 1999
21. Larson RS, Brown DC, Sklar LA: Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB4 by utilization of LFA1 and ICAM-2. Blood 90:2747-2756, 1997
22. Di Noto R, Schiavone EM, Ferrara F, et al: All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells. Br J Haematol 88:247-255, 1994
23. Di Noto R, Schiavone EM, Ferrara F, et al: Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 8:1900-1905, 1994
24. Lanier LL, Testi R, Bindl J, et al: Identity of Leu 19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169:2233-2239, 1989
25. Baer MR, Stewart CC, Lawrence D, et al: Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 90:1643-1648, 1997
26. Murray CK, Estey E, Paietta E, et al: CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome? J Clin Oncol 17:293-297, 1999
27. Scott AA, Head DR, Kopecky KJ, et al: HLA-DR-, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: A previously unrecognized from of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84:244-255, 1994
28. Suzuki R, Yamamoto K, Seto M, et al: CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity. Blood 90:2417-2428, 1997
29. Bennett JM, Catovsky D, Daniel MT, et al: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625, 1985
30. Avvisati G, Lo Coco F, Diverio D, et al: AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood 88:1390-1398, 1996
31. Cheson BD, Cassileth PA, Head DR, et al: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813-819, 1990
32. Armitage P, Berry G: Statistical Methods in Medical Research. Boston, MA, Blackwell, 1987
33. Kaplan EL, Meier P: Non parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
34. Cox DR: Regression models and life-tables. J R Stat Soc 33:187-220, 1972
35. Meloni G, Diverio D, Vignetti M, et al: Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood 90:1321-1326, 1997
36. Vahdat L, Maslak P, Miller WH, et al: Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843-3849, 1994
37. Byrd JC, Edenfield WJ, Shields DS, et al: Extramedullary myeloid tumors in acute nonlymphocytic leukemia: A clinical review. J Clin Oncol 13:1800-1816, 1995
38. Tallman MS, Hakimian D, Shaw JM, et al: Granulocytic sarcoma is associated with the t(8;21) translocation in acute myeloid leukemia. J Clin Oncol 11:690-697, 1995
39. Strout MP, Marcucci G, Caligiuri MA, et al: Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: Biology and clinical implications. Ann Hematol 78:251-264, 1999